Minimal but essential doses of immunosuppression: a more realistic approach to improve long-term outcomes for pediatric living-donor liver transplantation.
1 Department of Surgery; Graduate School of Medicine; Kyoto University; Kyoto, Japan (Ohe, Nafady-Hego, Uemoto, Koshiba) 2 Department of Experimental Pathology; Institute for Frontier Medical Science; Kyoto University; Kyoto, Japan (Li, Sakaguchi) 3 Department of Ubiquitous Health Informatics; Graduate school of Medicine; The University of Tokyo; Tokyo, Japan (Kayo) 4 Transplantation Research Immunology Group; Nuffield Department of Surgery; University of Oxford; John Radcliffe Hospital; Headington, Oxford, United Kingdom (Wood) 5 Department of Surgery & Medicine; University of Cambridge; United Kingdom and National University of Singapore, Singapore (Calne).Transplantation (impact factor: 4). 04/2011; 91(7):808-10. DOI:10.1097/TP.0b013e31820f07de
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.